Concise Review: Cheating Death for a Better Transplant

Stem Cells
Sehar AfreenMiriam Erlacher

Abstract

Hematopoietic stem cell transplantation is routinely performed for the treatment of various malignant and non-malignant hematological diseases. Successful transplantation depends on the number and fitness of donor stem and progenitor cells, whose quality is substantially influenced by the sampling procedure, sample handling, and cryopreservation. BCL-2 proteins are central to the survival and maintenance of stem and progenitor cells under both, physiological and stress conditions. Transplantation-associated apoptosis of donor cells is mediated by the pro-apoptotic BCL-2 proteins BIM and BMF and prevented by overexpression of their antagonists, BCL-2 and BCL-XL. We have previously reported that deletion of BIM or BMF stabilizes donor stem cell numbers during transplantation and improves cellular fitness and transplantation outcomes, albeit posing a risk for lymphoma and autoimmunity in recipient mice. Short-term apoptosis inhibition in donor cells appears equally effective in improving the outcome of transplantation, but in contrast does not cause pathology. In this review, we discuss the role of BCL-2 proteins in the context of factors that negatively impact donor stem and progenitor cell fitness and viability. Finally, we sugg...Continue Reading

References

Sep 1, 1984·The American Journal of Physiology·P Mazur
Mar 10, 1995·Science·S Nagata, P Golstein
Nov 26, 1998·The New England Journal of Medicine·P RubinsteinC E Stevens
Feb 9, 1999·Results and Problems in Cell Differentiation·D R Green, G P Amarante-Mendes
Jun 18, 1999·Annals of the New York Academy of Sciences·R HandgretingerT Klingebiel
Sep 19, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Christopher StrohMarek Los
Aug 18, 2004·Science·Kent W ChristophersonHal E Broxmeyer
Dec 31, 2004·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Christian ScheffoldJudith A Shizuru
Feb 19, 2005·Science·Joseph T OpfermanStanley J Korsmeyer
Jun 15, 2007·Toxicologic Pathology·Susan Elmore
Jan 1, 2008·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Jonas MattssonRainer Storb
Oct 14, 2008·Stem Cells and Development·Hilal GulAnna Janowska-Wieczorek
Apr 7, 2010·Cell Stem Cell·Tanya Bondar, Ruslan Medzhitov
Jul 14, 2010·Cell Stem Cell·Mary MohrinEmmanuelle Passegué
Jul 14, 2010·Trends in Immunology·Charlotte SummersEdwin R Chilvers
Aug 30, 2011·Bone Marrow Transplantation·Ş M Bakanay, T Demirer
Jun 27, 2013·Wiley Interdisciplinary Reviews. Developmental Biology·John Tower
Mar 4, 2014·Stem Cells·Malte von Bonin, Martin Bornhäuser

❮ Previous
Next ❯

Citations

Mar 29, 2020·Cell Death Discovery·Ivano Amelio, Gerry Melino
Feb 11, 2021·Cell Death Discovery·Ivano Amelio, Gerry Melino
May 4, 2021·Journal of Medicinal Chemistry·Justin P PogmoreDavid W Andrews
May 13, 2021·ACS Applied Materials & Interfaces·Shreyas KuddannayaJeff W M Bulte

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis
S Civriz BozdagO Ilhan
Nature Reviews. Molecular Cell Biology
Rachel David
Acta Medica Croatica : C̆asopis Hravatske Akademije Medicinskih Znanosti
Drago Batinić
© 2022 Meta ULC. All rights reserved